144 related articles for article (PubMed ID: 38045968)
21. COVID-19 mass vaccination - an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns.
Roseline M; Luc C; Julien L; Olivier E; Etienne B; Pierrick B
Emerg Microbes Infect; 2022 Dec; 11(1):804-806. PubMed ID: 35230221
[TBL] [Abstract][Full Text] [Related]
22. Validation Checklist for Massive Vaccination Centers.
Capolongo S; Brambilla A; Girardi A; Signorelli C
Ann Ig; 2021; 33(5):513-517. PubMed ID: 34224553
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].
Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F
Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208
[TBL] [Abstract][Full Text] [Related]
24. An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status.
Lumley SF; Rodger G; Constantinides B; Sanderson N; Chau KK; Street TL; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Stoesser NE; Matthews PC; Jeffery K; Eyre DW;
Clin Infect Dis; 2022 Apr; 74(7):1208-1219. PubMed ID: 34216472
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
[TBL] [Abstract][Full Text] [Related]
26. Burden of COVID-19 and Vaccination Coverage in the Italian Population as of October 2021.
Altobelli E; Marzi F; Angelone AM; Mazzocca R; Mastrodomenico M; Petrocelli R; Marziliano C
Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010756
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy).
Consonni D; Lombardi A; Mangioni D; Bono P; Oggioni M; Uceda Renteria S; Valzano A; Bordini L; Nava CD; Tiwana N; Gentiloni Silverj F; Castaldi S; Rognoni M; Cavalieri D'Oro L; Carugno M; Luisetti G; Riboldi L; Ceriotti F; Bandera A; Gori A; Pesatori AC
Epidemiol Prev; 2022; 46(4):250-258. PubMed ID: 36259341
[TBL] [Abstract][Full Text] [Related]
28. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 Vaccine Hesitancy and Early Adverse Events Reported in a Cohort of 7,881 Italian Physicians.
Monami M; Gori D; Guaraldi F; Montalti M; Nreu B; Burioni R; Mannucci E
Ann Ig; 2022; 34(4):344-357. PubMed ID: 34821928
[TBL] [Abstract][Full Text] [Related]
30. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
[TBL] [Abstract][Full Text] [Related]
31. The contribution of the private healthcare sector during the COVID-19 pandemic: the experience of the Lombardy Region in Northern Italy.
Signorelli C; De Ponti E; Mastrangelo M; Pennisi F; Cereda D; Corti F; Beretta D; Pelissero G
Ann Ig; 2024; 36(2):250-255. PubMed ID: 38303641
[TBL] [Abstract][Full Text] [Related]
32. Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.
Li Q; Norman S; Guthrie P; Gachoya J; Sebakijje J; Leftridge Z; Willis CG; Kishore A; Breakenridge M; Spence C
Am J Health Syst Pharm; 2021 Sep; 78(18):1724-1731. PubMed ID: 33895789
[TBL] [Abstract][Full Text] [Related]
33. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
34. Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy.
Corrao G; Franchi M; Cereda D; Bortolan F; Leoni O; Vignati E; Pavesi G; Gori A
BMC Infect Dis; 2022 Nov; 22(1):844. PubMed ID: 36371165
[TBL] [Abstract][Full Text] [Related]
35. Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.
Powell J; Piszczatoski CR
Ann Pharmacother; 2022 Sep; 56(9):1058-1064. PubMed ID: 35012364
[TBL] [Abstract][Full Text] [Related]
36. Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January-June 2021.
Peebles K; Arciuolo RJ; Romano AS; Sell J; Greene SK; Lim S; Mulready-Ward C; Ternier A; Badenhop B; Blaney K; Real JE; Spencer M; McPherson TD; Ahuja SD; Sullivan Meissner J; Zucker JR; Rosen JB
J Infect Dis; 2023 Feb; 227(4):533-542. PubMed ID: 36626187
[TBL] [Abstract][Full Text] [Related]
37. Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns.
Beccia F; Lontano A; Rossi MF; Marziali E; Pascucci D; Raponi M; Santoro PE; Moscato U; Laurenti P
Hum Vaccin Immunother; 2023 Aug; 19(2):2252708. PubMed ID: 37706326
[TBL] [Abstract][Full Text] [Related]
38. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
[TBL] [Abstract][Full Text] [Related]
39. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
[TBL] [Abstract][Full Text] [Related]
40. Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy.
Corrao G; Franchi M; Cereda D; Bortolan F; Zoli A; Leoni O; Borriello CR; Valle GPD; Tirani M; Pavesi G; Barone A; Ercolanoni M; Jara J; Galli M; Bertolaso G; Mancia G
Lancet Infect Dis; 2022 May; 22(5):649-656. PubMed ID: 35093194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
